<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lauren Cohee, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karl Seydel, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Johanna Daily, MD, MSc
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elinor L Baron, MD, DTMH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 17, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical manifestations of malaria vary with parasite species, epidemiology, immunity, and age.
        </p>
        <p>
         Issues related to clinical manifestations and diagnosis of malaria will be reviewed here. Technical aspects of laboratory tools for diagnosis of malaria are discussed further separately.
        </p>
        <p>
         The epidemiology, pathogenesis, diagnosis, and treatment of malaria are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5702.html" rel="external">
          "Malaria: Epidemiology, prevention, and control"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5704.html" rel="external">
          "Treatment of uncomplicated falciparum malaria in nonpregnant adults and children"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5667.html" rel="external">
          "Treatment of severe malaria"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4812.html" rel="external">
          "Malaria in pregnancy: Prevention and treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5706.html" rel="external">
          "Non-falciparum malaria: P. vivax, P. ovale, and P. malariae"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/112633.html" rel="external">
          "Non-falciparum malaria: Plasmodium knowlesi"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1851826331">
         <span class="h1">
          RISK GROUPS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In areas where malaria is highly endemic, groups at highest risk include young children (6 to 59 months), who can develop severe illness, and pregnant individuals, who are at risk for anemia and delivering low birthweight newborns. In areas where malaria is transmitted throughout the year, older children and adults develop partial immunity after repeated infections and are at relatively low risk for severe disease.
        </p>
        <p>
         Travelers to malarious areas generally have had no previous exposure to malaria parasites or have lost their immunity if they left the endemic area; they are at very high risk for severe disease if infected with
         <em>
          Plasmodium falciparum
         </em>
         [
         <a href="#rid1">
          1,2
         </a>
         ]. For this reason, it is important to consider malaria in all febrile patients with history of travel to malarious areas.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          INCUBATION PERIOD
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following the bite of an infected female
         <em>
          Anopheles
         </em>
         mosquito, the inoculated sporozoites migrate to the liver within one to two hours  (
         <a class="graphic graphic_figure graphicRef58397" href="/z/d/graphic/58397.html" rel="external">
          figure 1
         </a>
         ). Individuals are generally asymptomatic for 12 to 35 days after infection, but symptoms can commence as early as 7 days (depending on parasite species). Symptoms begin during the erythrocytic stage of the parasite life cycle, when infected red cells rupture and release merozoites, leading to fever and other symptoms.
        </p>
        <p>
         In most cases, infections due to
         <em>
          P. falciparum
         </em>
         become clinically apparent within one month after exposure [
         <a href="#rid3">
          3-5
         </a>
         ]. Longer incubation periods are more likely in semi-immune individuals and individuals taking incompletely effective malaria prophylaxis.
        </p>
        <p>
         The incubation period for the relapsing species,
         <em>
          Plasmodium vivax
         </em>
         and
         <em>
          Plasmodium ovale
         </em>
         , is also about two weeks; however, illness can occur months after initial infection due to activation of residual hypnozoites in the liver [
         <a href="#rid3">
          3,6,7
         </a>
         ]. Relapses generally occur within two to three years of infection; with even longer periods of dormancy being reported [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         The incubation period for
         <em>
          Plasmodium malariae
         </em>
         is about 18 days; however, low-grade asymptomatic infections can very rarely persist for years  (
         <a class="graphic graphic_table graphicRef53291" href="/z/d/graphic/53291.html" rel="external">
          table 1
         </a>
         ).
         <em>
          P. falciparum
         </em>
         and
         <em>
          P. malariae
         </em>
         have no dormant (hypnozoite) phase, hence do not relapse. (See
         <a class="medical medical_review" href="/z/d/html/5706.html" rel="external">
          "Non-falciparum malaria: P. vivax, P. ovale, and P. malariae"
         </a>
         .)
        </p>
        <p>
         Two primate malarias,
         <em>
          Plasmodium knowlesi
         </em>
         and
         <em>
          Plasmodium simium,
         </em>
         have been shown to infect humans in Southeast Asia and Brazil, respectively;
         <em>
          P. knowlesi
         </em>
         resembles
         <em>
          P. malariae,
         </em>
         and
         <em>
          P. simium
         </em>
         resembles
         <em>
          P. vivax
         </em>
         (via microscopy and polymerase chain reaction) [
         <a href="#rid9">
          9
         </a>
         ]. There is an expanding number of
         <em>
          Plasmodium
         </em>
         species that typically infect nonhuman primates but could cross over to humans; however, whether they are a source of human disease is debated.
        </p>
        <p class="headingAnchor" id="H3643594665">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2995286154">
         <span class="h2">
          Uncomplicated malaria
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Uncomplicated falciparum malaria
         </strong>
         − Uncomplicated falciparum malaria consists of symptomatic infection due to
         <em>
          P. falciparum
         </em>
         (established via a positive parasitologic test), in the absence of symptoms and signs consistent with severe malaria  (
         <a class="graphic graphic_table graphicRef107439" href="/z/d/graphic/107439.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Signs and symptoms
         </strong>
         − Malaria should be suspected in patients with febrile illness who have had exposure to a region where malaria is endemic [
         <a href="#rid1">
          1,2,7
         </a>
         ]. The initial symptoms are nonspecific and may also include tachycardia, tachypnea, chills, malaise, fatigue, diaphoresis, headache, cough, anorexia, nausea, vomiting, abdominal pain, diarrhea, arthralgias, and myalgias [
         <a href="#rid2">
          2,7
         </a>
         ]. Individuals with uncomplicated disease are generally able to swallow antimalarial drugs.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Fever
         </strong>
         − Early in the course of malaria infection, febrile paroxysms occur at irregular intervals each day. In children and nonimmune adults, the temperature may rise above 40°C and may occur in conjunction with tachycardia and/or delirium. Febrile seizures may occur among children in the setting of malaria due to any species. However, generalized seizures are associated with
         <em>
          P. falciparum
         </em>
         infection and may herald the development of cerebral malaria. (See
         <a class="local">
          'Cerebral malaria'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">
          "Clinical features and evaluation of febrile seizures"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         Later in the course of infection, rupture of infected red cells can become synchronous following concurrent schizont rupture and release of merozoites from erythrocytes  (
         <a class="graphic graphic_figure graphicRef58397" href="/z/d/graphic/58397.html" rel="external">
          figure 1
         </a>
         ). Febrile paroxysms may occur every other day for
         <em>
          P. vivax
         </em>
         ,
         <em>
          P. ovale
         </em>
         , and
         <em>
          P. falciparum
         </em>
         and every third day for
         <em>
          P. malariae
         </em>
         . Paroxysms occurring at regular intervals are more common in the setting of infection due to
         <em>
          P. vivax
         </em>
         or
         <em>
          P. ovale
         </em>
         than
         <em>
          P. falciparum
         </em>
         . With improvements in early diagnosis and treatment, this traditional description of cyclic fever is seen infrequently.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         Febrile illness may reflect concomitant infection. The lower the parasitemia, the greater the chance of a lower respiratory tract, intestinal, or bloodstream bacterial or viral infection [
         <a href="#rid10">
          10,11
         </a>
         ]. (See
         <a class="local">
          'Concomitant infection'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Physical findings
         </strong>
         − Physical findings may include manifestations of anemia (lethargy, pallor) and a palpable spleen in some cases; splenic enlargement supports the diagnosis if present but may also reflect other conditions. In endemic areas, anemia is common among young children and is often due to multiple causes in addition to malaria (including iron and other nutritional deficiencies as well as helminth infection) [
         <a href="#rid12">
          12
         </a>
         ]. Mild jaundice may develop in patients with otherwise uncomplicated falciparum malaria. (See
         <a class="medical medical_review" href="/z/d/html/7112.html" rel="external">
          "Anemia in malaria"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Laboratory findings
         </strong>
         − Laboratory evaluation may demonstrate parasitemia (usually &lt;5000 parasites/microL of blood, &lt;0.1 percent parasitized red blood cells [RBCs]), anemia, thrombocytopenia, elevated transaminases, mild coagulopathy, and elevated blood urea nitrogen (BUN) and creatinine.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other species
         </strong>
         − Uncomplicated malaria can occur with other
         <em>
          Plasmodium
         </em>
         species as well. It is often not possible to determine the species of malaria infection on clinical grounds alone; there are some unique characteristics associated with each species.
         <em>
          P. vivax
         </em>
         ,
         <em>
          P. ovale
         </em>
         ,
         <em>
          P. malariae
         </em>
         , and
         <em>
          P. knowlesi
         </em>
         are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5706.html" rel="external">
          "Non-falciparum malaria: P. vivax, P. ovale, and P. malariae"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112633.html" rel="external">
          "Non-falciparum malaria: Plasmodium knowlesi"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Severe malaria
         </span>
         <span class="headingEndMark">
          —
         </span>
         Severe malaria is defined as presence of
         <em>
          P. falciparum
         </em>
         parasitemia and one or more of the manifestations in the table  (
         <a class="graphic graphic_table graphicRef107439" href="/z/d/graphic/107439.html" rel="external">
          table 2
         </a>
         ).
         <em>
          P. knowlesi
         </em>
         ,
         <em>
         </em>
         which is restricted
         <em>
         </em>
         to Southeast Asia, can also cause severe disease. It is acquired in forested regions as a predominately zoonotic infection via mosquito transmission from simian hosts (
         <em>
          Macaca fascicularis
         </em>
         and
         <em>
          Macaca nemestrina).
         </em>
         (See
         <a class="medical medical_review" href="/z/d/html/112633.html" rel="external">
          "Non-falciparum malaria: Plasmodium knowlesi"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4160476600">
         <span class="h3">
          General principles
         </span>
         <span class="headingEndMark">
          —
         </span>
         Manifestations of severe malaria are summarized in the table  (
         <a class="graphic graphic_table graphicRef107439" href="/z/d/graphic/107439.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid13">
          13,14
         </a>
         ].
        </p>
        <p>
         Many of the clinical findings are the result of the parasitized RBCs adhering to the endothelial cells lining small blood vessels ("cytoadherence") causing small infarcts, capillary leakage, and organ dysfunction. These include the following [
         <a href="#rid7">
          7,15,16
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Altered consciousness
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe anemia (eg massive intravascular hemolysis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypoglycemia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory distress or acute respiratory distress syndrome (ARDS)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coagulopathy, with or without disseminated intravascular coagulation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic acidosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Circulatory collapse
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal failure, hemoglobinuria ("blackwater fever")
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatic failure
        </p>
        <p>
        </p>
        <p>
         Physical findings may include pallor, petechiae, jaundice, hepatomegaly, and/or splenomegaly. Splenic rupture has been described. Diagnostic evaluation may demonstrate the following: parasitemia ≥4 to 10 percent, anemia, thrombocytopenia, coagulopathy, elevated transaminases, elevated BUN/creatinine, acidosis, and hypoglycemia [
         <a href="#rid7">
          7,17,18
         </a>
         ]. Thrombocytopenia has been associated with increased risk of death from falciparum or vivax malaria, particularly in the setting of concurrent severe anemia [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         The clinical manifestations of severe malaria vary with age and geography. In areas where malaria is endemic, young children (ages two to five years) are at high risk for severe malaria, as are pregnant individuals. Older children and adults develop partial immunity to febrile malaria episodes (but not to malaria infection) after repeated infection and thus are at lower risk for severe disease [
         <a href="#rid20">
          20
         </a>
         ]. Travelers to areas where malaria is endemic with no previous exposure to malaria parasites are at higher risk for progression to severe disease if infected with
         <em>
          P. falciparum
         </em>
         [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="local">
          'Children versus adults'
         </a>
         below.)
        </p>
        <p>
         While most severe malaria is usually due to
         <em>
          P. falciparum
         </em>
         , patients with severe malaria due to
         <em>
          P. vivax
         </em>
         have also been described. Patients with severe
         <em>
          P. vivax
         </em>
         may manifest pulmonary complications and ARDS [
         <a href="#rid22">
          22
         </a>
         ]. Those at greatest risk for severe disease include nonimmune individuals, immunocompromised patients (including asplenic individuals), children 6 to 59 months of age, and pregnant individuals [
         <a href="#rid7">
          7,23
         </a>
         ]. Increasing parasitemia is associated with increasing disease severity. Semi-immune individuals may have substantial parasitemia with few or no clinical manifestations. However, some severely ill or inadequately treated patients may have a low but rising parasitemia when first seen by a clinician. (See
         <a class="medical medical_review" href="/z/d/html/5707.html" rel="external">
          "Laboratory tools for diagnosis of malaria"
         </a>
         .)
        </p>
        <p>
         Manifestations of severe malaria can portend a grave prognosis; such patients should receive a prompt and thorough evaluation and immediate treatment [
         <a href="#rid24">
          24,25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5667.html" rel="external">
          "Treatment of severe malaria"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Cerebral malaria
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         − Cerebral malaria is an encephalopathy that presents with impaired consciousness, delirium, and/or seizures; focal neurologic signs are unusual. The onset may be gradual or sudden, following a convulsion. The severity depends on a combination of factors including parasite virulence and host immune response.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         − Risk factors for cerebral malaria include age (children and older adults), pregnancy, poor nutritional status, host genetic susceptibility, and history of splenectomy [
         <a href="#rid26">
          26-29
         </a>
         ]. Among adults, cerebral malaria occurs more commonly among nonimmune individuals than among those living in highly endemic areas.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lumbar puncture findings
         </strong>
         − In children with cerebral malaria, the mean opening pressure is about 22 cm H
         <sub>
          2
         </sub>
         O; approximately 80 percent of patients having elevated opening pressure [
         <a href="#rid30">
          30,31
         </a>
         ]. Laboratory examination of cerebrospinal fluid (CSF) is generally normal.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In one study comparing CSF findings from 12 children with cerebral malaria and 14 children with presumed viral encephalitis, lower white cell count, glucose, and protein levels were observed among patients with cerebral malaria [
         <a href="#rid32">
          32
         </a>
         ]. Children with malaria had mean white cell count of 0 cells/microL (range 0 to 4 cells/microL); children with viral encephalitis had mean white cell count of 4 cells/microL (range 0 to 9 cells/microL). A CSF glucose concentration below 3.4 mmol/L (61 mg/dL) was the best discriminator of cerebral malaria from presumed viral encephalitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Retinopathy
         </strong>
         − Retinal hemorrhages may be observed in 30 to 40 percent of cases via pupillary dilation and indirect ophthalmoscopy; without pupillary dilation, this finding may be seen in approximately 15 percent of cases. Other funduscopic abnormalities include discrete spots of retinal opacification (30 to 60 percent), cotton wool spots (&lt;5 percent), and decolorization of a retinal vessel or segment of vessel  (
         <a class="graphic graphic_picture graphicRef65241" href="/z/d/graphic/65241.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef64492" href="/z/d/graphic/64492.html" rel="external">
          picture 2
         </a>
         and
         <a class="graphic graphic_picture graphicRef50690" href="/z/d/graphic/50690.html" rel="external">
          picture 3
         </a>
         ) [
         <a href="#rid33">
          33
         </a>
         ]. Inclusion of malarial retinopathy in the World Health Organization clinical definition of cerebral malaria increases the diagnostic sensitivity and specificity to 90 and 95 percent, respectively (with presence of parasites in the brain on autopsy as the ‘gold standard’) [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cerebral edema
         </strong>
         − Cerebral edema and elevated intracranial pressure may contribute to a fatal outcome  (
         <a class="graphic graphic_picture graphicRef100470" href="/z/d/graphic/100470.html" rel="external">
          picture 4
         </a>
         ). In one study including 164 children with cerebral malaria, approximately 84 percent of deaths occurred among individuals with evidence of severe brain swelling on magnetic resonance imaging at admission  (
         <a class="graphic graphic_picture graphicRef100470" href="/z/d/graphic/100470.html" rel="external">
          picture 4
         </a>
         ); such swelling was noted among 27 percent of survivors [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sequelae
         </strong>
         − Among survivors of cerebral malaria, neurologic sequelae are more common among children than adults (about 50 versus 3 percent, respectively) [
         <a href="#rid36">
          36
         </a>
         ]. Residual deficits may include hemiplegia, cerebral palsy, cortical blindness, deafness, epilepsy, language deficit, and impaired cognition [
         <a href="#rid37">
          37,38
         </a>
         ]. Such sequelae are more likely among patients with other grave prognostic indicators including hypoglycemia, acidosis, severe anemia, repeated seizures, and deep coma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Postmalaria neurologic syndrome is an autoimmune encephalitis that manifests within two months of treatment and resolution of cerebral malaria. The condition is rare, presents often with seizures, and responds to parenteral steroids [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Hypoglycemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypoglycemia is a common complication of severe malaria, although the usual signs (sweating, tachycardia, neurologic impairment) are difficult to distinguish from systemic symptoms due to severe malaria. Hypoglycemia occurs as a result of the following factors:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diminished hepatic gluconeogenesis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depletion of liver glycogen stores
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increase in the consumption of glucose by the host (and, to a much lesser extent, the parasite)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Quinine-induced hyperinsulinemia
        </p>
        <p>
        </p>
        <p>
         Hypoglycemia is associated with a poor prognosis, particularly in children and pregnant individuals.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Acidosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acidosis is an important clinical finding in severe malaria and must be corrected quickly. It is caused by several factors, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anaerobic glycolysis in host tissues where sequestered parasites interfere with microcirculatory flow
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Parasite lactate production
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypovolemia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Insufficient hepatic and renal lactate clearance
        </p>
        <p>
        </p>
        <p>
         The prognosis of severe acidosis is poor.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Renal impairment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Renal impairment is common among adults with severe falciparum malaria. Historically, renal involvement has not been considered to be a major component of pediatric severe malaria. However, over the past decade, improved estimates of glomerular filtration rate and creatinine measurement have demonstrated the importance of considering renal impairment in children [
         <a href="#rid40">
          40,41
         </a>
         ]. The frequency of estimated acute kidney injury (AKI) in pediatric severe malaria ranges from 24 to 59 percent [
         <a href="#rid42">
          42
         </a>
         ]. Patients with AKI are at increased risk for mortality [
         <a href="#rid41">
          41
         </a>
         ], chronic kidney disease [
         <a href="#rid43">
          43
         </a>
         ], and postdischarge behavioral problems [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
         The pathogenesis of renal failure is uncertain but may be related to erythrocyte sequestration interfering with renal microcirculatory flow and metabolism. Other potential factors include hypovolemia and hemolysis [
         <a href="#rid45">
          45
         </a>
         ]. Large amounts of hemoglobin and malarial pigments may be present in the urine secondary to intravascular hemolysis. This uncommonly manifests in very dark urine following several attacks of falciparum malaria; mortality is high. Renal impairment can manifest as acute tubular necrosis (both clinically and pathologically), although renal cortical necrosis does not occur.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Noncardiogenic pulmonary edema
         </span>
         <span class="headingEndMark">
          —
         </span>
         Noncardiogenic pulmonary edema (eg, acute respiratory distress syndrome) may be observed in adults with severe falciparum malaria [
         <a href="#rid46">
          46
         </a>
         ]. The pathogenesis is uncertain but may be related to sequestration of parasitized red cells in the lungs and/or cytokine-induced leakage from the pulmonary vasculature. This complication may develop even after several days of antimalarial therapy and can be aggravated by overly vigorous administration of intravenous fluid [
         <a href="#rid24">
          24
         </a>
         ]. Noncardiogenic pulmonary edema can also develop in otherwise uncomplicated vivax malaria. (See
         <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">
          "Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"
         </a>
         .)
        </p>
        <p>
         Children with severe anemia may present with deep, labored respirations. This is usually due to metabolic acidosis (often compounded by hypovolemia).
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Hematologic abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anemia is usually mild to moderate, though severe anemia may occur in the setting of
         <em>
          P. falciparum
         </em>
         malaria. In one series including 100 Canadian travelers, patients with malaria presented with anemia in 41 percent of cases [
         <a href="#rid47">
          47
         </a>
         ]. White blood cell counts were elevated above 9.8 x 10
         <sup>
          9
         </sup>
         /L in 3 percent of patients but were less than 5.0 x 10
         <sup>
          9
         </sup>
         /L in 48 percent. Platelets were low in 83 percent of
         <em>
          P. vivax
         </em>
         -infected patients (mean 102 x 10
         <sup>
          9
         </sup>
         /L) and in 62 percent of
         <em>
          P. falciparum
         </em>
         -infected patients (mean 137 x 10
         <sup>
          9
         </sup>
         /L).
        </p>
        <p>
         Children in endemic areas with serial episodes of malaria infection may develop severe chronic anemia. In nonimmune individuals and in areas with unstable transmission, anemia can develop acutely. Anemia in the setting of malaria occurs as a result of the following factors:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hemolysis of parasitized red cells
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased splenic sequestration and clearance of erythrocytes with diminished deformability
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cytokine suppression of hematopoiesis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Shortened erythrocyte survival
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Repeated infections and ineffective treatments
        </p>
        <p>
        </p>
        <p>
         Additional information regarding these mechanisms is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/7112.html" rel="external">
          "Anemia in malaria"
         </a>
         .)
        </p>
        <p>
         Coagulopathy can occur in the setting of falciparum malaria; bleeding with evidence of disseminated intravascular coagulation occurs in &lt;5 percent of patients with severe malaria. (See
         <a class="medical medical_review" href="/z/d/html/1306.html" rel="external">
          "Evaluation and management of disseminated intravascular coagulation (DIC) in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Liver dysfunction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mild jaundice due to hemolysis in malaria is common in adults. Severe jaundice due to hemolysis, hepatocyte injury, and cholestasis may occur in the setting of
         <em>
          P. falciparum
         </em>
         infection; this manifestation is more common among adults than children. Liver dysfunction together with renal impairment and other organ dysfunction portend a poor prognosis [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Concomitant infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         There appears to be a biological association between malaria, human immunodeficiency virus (HIV), malnutrition, and invasive bacterial infections. These conditions occur often in malarious areas, as do geohelminths; the latter contribute greatly to anemia and malnutrition, especially in children [
         <a href="#rid12">
          12,48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1298181994">
         <span class="h4">
          Bacterial infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Septicemia may complicate severe malaria, particularly in children [
         <a href="#rid48">
          48
         </a>
         ]. In endemic areas,
         <em>
          Salmonella
         </em>
         bacteremia has been associated with
         <em>
          P. falciparum
         </em>
         infections [
         <a href="#rid49">
          49
         </a>
         ]. Chest infections and catheter-induced urinary tract infections are common among patients who are unconscious for ≥3 days. Aspiration pneumonia may follow generalized seizures.
        </p>
        <p class="headingAnchor" id="H402184799">
         <span class="h4">
          HIV infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         HIV and malaria often coexist. HIV infection is associated with increased susceptibility to malaria, higher parasitemia, and increased risk for recurrent malaria infection, particularly in patients with CD4 counts &lt;200 cells/microL [
         <a href="#rid50">
          50
         </a>
         ]. HIV and malaria independently lead to anemia. Coinfection may be associated with anemia of greater severity among children
         <em>
          P. falciparum
         </em>
         infection in children [
         <a href="#rid51">
          51
         </a>
         ]. In addition, malaria infection in patients with HIV infection has been associated with more rapid CD4 cell decline relative to patients with HIV infection in the absence of malaria [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         In some circumstances malaria infection has been associated with a transient increase in HIV viral load; however, this does not appear to hasten progression to acquired immunodeficiency syndrome (AIDS) [
         <a href="#rid53">
          53-57
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h3">
          Children versus adults
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical manifestations of malaria vary between children and adults [
         <a href="#rid58">
          58
         </a>
         ]. Seizures and severe anemia are more common in children, whereas hyperparasitemia, ARDS, and jaundice are more common in adults [
         <a href="#rid58">
          58
         </a>
         ]. Cerebral malaria (with coma), shock, acidosis, renal impairment, and respiratory arrest may occur at any age [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         It can be difficult to distinguish congenital malaria infection from malaria infection acquired as a newborn. Among infants with congenital malaria, onset of clinical manifestations usually occurs at two to eight weeks of age; signs and symptoms include poor feeding, fever, vomiting, diarrhea, and irritability. Anemia, thrombocytopenia, and hyperbilirubinemia are common [
         <a href="#rid59">
          59
         </a>
         ]. Splenomegaly is more common than hepatomegaly. Issues related to vertical transmission of malaria are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4795.html" rel="external">
          "Malaria in pregnancy: Epidemiology, clinical manifestations, diagnosis, and outcome", section on 'Vertical transmission'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H248081891">
         <span class="h2">
          Recurrent malaria infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recurrence of malaria can occur as a result of treatment failure (recrudescence), relapse, or reinfection; these may be difficult to distinguish. Both recrudescent and relapsing infections manifest as return of disease after its apparent cessation. Recrudescence occurs most often within days or weeks; relapse occurs within weeks or months. In recrudescence, parasites remain in the bloodstream undetected due to ineffective treatment or host immunological response (or both). In relapse, new blood stage parasites are released from dormant parasite stages (hypnozoites) in liver cells, causing a repeat episode of peripheral parasitemia.
        </p>
        <p>
         <em>
          P. falciparum
         </em>
         is the usual cause of recrudescent infection, although
         <em>
          P. malariae
         </em>
         can remain present at low levels of parasitemia for years prior to clinical presentation [
         <a href="#rid60">
          60
         </a>
         ].
         <em>
          P. vivax
         </em>
         and
         <em>
          P. ovale
         </em>
         may cause relapse months after the primary blood stage infection is cured, as these species have hypnozoite forms; the likelihood of relapse is decreased if the patient took presumptive anti-relapse therapy to eradicate the dormant hypnozoite liver stages. (See
         <a class="medical medical_review" href="/z/d/html/5706.html" rel="external">
          "Non-falciparum malaria: P. vivax, P. ovale, and P. malariae", section on 'Preventing relapse'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2707127954">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uncomplicated falciparum malaria consists of symptomatic
         <em>
          P. falciparum
         </em>
         infection with a positive parasitologic test, in the absence of symptoms consistent with severe malaria  (
         <a class="graphic graphic_table graphicRef107439" href="/z/d/graphic/107439.html" rel="external">
          table 2
         </a>
         ). Severe malaria is defined as presence of
         <em>
          P. falciparum
         </em>
         parasitemia and one or more of the manifestations in the table  (
         <a class="graphic graphic_table graphicRef107439" href="/z/d/graphic/107439.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Severe malaria'
         </a>
         above.)
        </p>
        <p>
         Malaria should be suspected in the setting of fever (temperature ≥37.5°C) and relevant epidemiologic exposure (residence in or travel to an area where malaria is endemic). In nonimmune individuals, most infections due to
         <em>
          P. falciparum
         </em>
         become clinically apparent within one month after exposure [
         <a href="#rid13">
          13
         </a>
         ]. In endemic areas with stable transmission and for areas with seasonal malaria during high-transmission season, malaria should also be suspected in children with palmar pallor or hemoglobin concentration &lt;8 g/dL.
        </p>
        <p>
         The diagnosis of malaria is definitively established in the setting of symptoms consistent with malaria and a positive malaria diagnostic test; diagnostic tools include light microscopy of blood smears and rapid diagnostic tests. For patients with suspected malaria, definitive diagnosis should be established [
         <a href="#rid13">
          13
         </a>
         ]. If initial diagnostic evaluation is negative and clinical suspicion for malaria persists, follow-up testing should be performed each day for two more days [
         <a href="#rid61">
          61
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5707.html" rel="external">
          "Laboratory tools for diagnosis of malaria", section on 'General principles'
         </a>
         .)
        </p>
        <p>
         If diagnostic tools are not readily available and there is clinical suspicion for
         <em>
          P. falciparum
         </em>
         infection, it may be reasonable to make a presumptive diagnosis (and treat empirically), given the potential severity of infection. Making a presumptive diagnosis depends on individual patient circumstances including epidemiologic exposure, clinical manifestations such as fever, and suggestive laboratory findings including anemia, in the absence of a clear alternative diagnosis. However, the clinical presentation of malaria overlaps with many other causes, and even in endemic areas, clinical diagnosis of malaria is frequently incorrect [
         <a href="#rid62">
          62-67
         </a>
         ]. Furthermore, empiric therapy may negatively affect the accuracy of subsequent diagnostic testing.
        </p>
        <p>
         In sub-Saharan Africa (where the burden of malaria is greatest), a definitive diagnosis of malaria among patients with fever is established in less than half of cases [
         <a href="#rid68">
          68-70
         </a>
         ]. One systemic review and meta-analysis including 21 studies (14 studies of endemic malaria and 7 studies of imported malaria) assessed the predictive value of clinical findings for diagnosis of malaria [
         <a href="#rid71">
          71
         </a>
         ]. In endemic areas, presence of splenomegaly and hepatomegaly were associated with increased likelihood of malaria (likelihood ratios [LRs] 3.3 [95% CI 2.0-4.7] and 2.4 [95% CI 1.6-3.6, respectively]). In returning travelers, presence of splenomegaly (LR 6.5, 95% CI 3.9-11.0), jaundice or icterus (LR 4.5, 95% CI 1.7-12.0), or pallor (LR 2.8, 95% CI 1.7-4.6) were associated with increased the likelihood of malaria. In addition, malaria was more likely in the setting of thrombocytopenia and hyperbilirubinemia (odds ratios 74.0 [95% CI 9.2-601.0] and 11 [95% CI 8-15], respectively).
        </p>
        <p>
         Individuals with acquired partial immunity due to repeated exposures in endemic settings may have asymptomatic parasitemia. There is no diagnostic test capable of distinguishing between parasitemia causing clinical malaria and febrile illness due to another cause in a patient who also has asymptomatic parasitemia. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
         Diagnostic tools include light microscopy and rapid diagnostic tests. Detailed discussion regarding these tools is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/5707.html" rel="external">
          "Laboratory tools for diagnosis of malaria"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of malaria is broad due to the nonspecific nature of symptoms, physical findings, and laboratory parameters (excluding parasitemia). In nonimmune populations (including travelers to endemic areas), a single diagnosis is likely; however, in immune or partially immune populations (including individuals residing in endemic areas), it is important to consider concomitant infections.
        </p>
        <p>
         The broad differential diagnosis includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dengue fever – Dengue fever can cause malaise, headache, fatigue, abdominal discomfort, and muscle aches in association with fever. Myalgia due to dengue fever is usually more severe than myalgia due to malaria. The diagnosis is established with serology. (See
         <a class="medical medical_review" href="/z/d/html/3025.html" rel="external">
          "Dengue virus infection: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chikungunya – Chikungunya resembles dengue but is milder and self-limiting, often with a rash. The diagnosis is established via serology. (See
         <a class="medical medical_review" href="/z/d/html/3024.html" rel="external">
          "Chikungunya fever: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meningitis – The headache of malaria may be severe, although there is no neck stiffness or photophobia as seen with bacterial or viral meningitis. Malaria is not associated with a rash (unlike meningococcal septicemia). The diagnosis of bacterial meningitis is established via lumbar puncture and culture. (See
         <a class="medical medical_review" href="/z/d/html/1287.html" rel="external">
          "Clinical features and diagnosis of acute bacterial meningitis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pneumonia – Clinical manifestations of pneumonia include fever, cough, dyspnea, and sputum production. Patients with pneumonia may have intercostal retractions and other signs of labored breathing. The diagnosis is of pneumonia established via chest radiography and sputum culture. (See
         <a class="medical medical_review" href="/z/d/html/7032.html" rel="external">
          "Clinical evaluation and diagnostic testing for community-acquired pneumonia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5986.html" rel="external">
          "Community-acquired pneumonia in children: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sepsis due to bacteremia – Sepsis due to bacteremia may present with fever, tachycardia, and altered mental status; diagnosis requires blood culture.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Typhoid fever – Clinical manifestations of typhoid fever include fever, bradycardia, abdominal pain, and rash. The diagnosis is established by stool and/or blood culture. (See
         <a class="medical medical_review" href="/z/d/html/2708.html" rel="external">
          "Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Leptospirosis – Leptospirosis is associated with fever, rigors, myalgia, and headache. Myalgia due to leptospirosis is usually more severe than in malaria; leptospirosis may also be associated with petechial hemorrhages in the skin or mucous membranes. The diagnosis is established by serologic testing. (See
         <a class="medical medical_review" href="/z/d/html/5527.html" rel="external">
          "Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viral hemorrhagic fever – Viral hemorrhagic fever is associated with fever, malaise, and systemic symptoms. It may be associated with petechial hemorrhages in the skin or mucous membranes; this occurs in severe malaria only rarely. The diagnosis is established by immunoassay or nucleic acid testing. (See
         <a class="medical medical_review" href="/z/d/html/3022.html" rel="external">
          "Clinical manifestations and diagnosis of Ebola virus disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2242986134">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113035.html" rel="external">
          "Society guideline links: Malaria"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10436000">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/85721.html" rel="external">
          "Patient education: Malaria (The Basics)"
         </a>
         )
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk groups
         </strong>
         – (See
         <a class="local">
          'Risk groups'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Individuals in endemic areas
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         In areas where malaria is endemic, groups at high risk for severe malaria and its consequences include young children (6 months to 5 years of age) and pregnant individuals. Older children and adults develop partial immunity after repeated infection and are at relatively low risk for severe disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         As disease incidence wanes, older age groups become more susceptible due to decreasing immunity. In addition, as areas within endemic regions (such as urban centers) reduce or eliminate transmission, residents in those areas are at increased risk when they travel to endemic areas within their own countries.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Travelers
         </strong>
         – Travelers to areas where malaria is endemic, including individuals from nonendemic areas and individuals who have been away from endemic areas, are at very high risk for severe disease if infected with
         <em>
          Plasmodium falciparum
         </em>
         . (See
         <a class="local">
          'Risk groups'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incubation period
         </strong>
         – The incubation period for
         <em>
          P. falciparum
         </em>
         infection is usually 12 to 14 days (range 7 to 30 days). Longer incubation periods are more likely in semi-immune individuals and individuals taking inadequate malaria prophylaxis at the time of infection. The relapsing malarias (
         <em>
          Plasmodium vivax
         </em>
         and
         <em>
          Plasmodium ovale
         </em>
         ) can cause clinical illness several weeks or months after the initial infection due to presence of hypnozoites in the liver. (See
         <a class="local">
          'Incubation period'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Malaria should be suspected in the setting of fever (temperature ≥37.5°C) and relevant epidemiologic exposure (residence in or travel to an area where malaria is endemic).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Uncomplicated malaria
         </strong>
         – Uncomplicated falciparum malaria consists of symptomatic infection due to
         <em>
          P. falciparum
         </em>
         (established via a positive parasitologic test) in a patient who can swallow medicines, in the absence of symptoms and signs consistent with severe malaria  (
         <a class="graphic graphic_table graphicRef107439" href="/z/d/graphic/107439.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Severe malaria
         </strong>
         – Severe malaria is defined as presence of
         <em>
          P. falciparum
         </em>
         parasitemia and one or more of the manifestations in the table  (
         <a class="graphic graphic_table graphicRef107439" href="/z/d/graphic/107439.html" rel="external">
          table 2
         </a>
         ). General principles regarding diagnosis of malaria are discussed above.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Children versus adults
         </strong>
         – Common manifestations among children with severe malaria include convulsions, coma, hypoglycemia, metabolic acidosis, severe anemia, and neurodevelopmental sequelae. Findings observed more frequently among adults than children include severe jaundice, acute respiratory distress syndrome, and acute pulmonary edema. (See
         <a class="local">
          'Children versus adults'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Definitive diagnosis
         </strong>
         – A definitive diagnosis of malaria is established in the setting of symptoms consistent with malaria and a positive malaria diagnostic test; diagnostic tools include light microscopy and rapid diagnostic tests. For patients with suspected malaria, definitive diagnosis should be established whenever possible. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Presumptive diagnosis
         </strong>
         – If diagnostic tools are not readily available and there is clinical suspicion for
         <em>
          P. falciparum
         </em>
         infection, it may be reasonable to make a presumptive diagnosis (and treat empirically), given the potential severity of infection. Making a presumptive diagnosis depends on individual patient circumstances including epidemiologic exposure, clinical manifestations such as fever, and suggestive laboratory findings including anemia, in the absence of a clear alternative diagnosis.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4023189593">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Joel Breman, MD, DTPH, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44:1560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Svenson JE, MacLean JD, Gyorkos TW, Keystone J. Imported malaria. Clinical presentation and examination of symptomatic travelers. Arch Intern Med 1995; 155:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria--implications for chemoprophylaxis in travelers. N Engl J Med 2003; 349:1510.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. International travel and health: Malaria. http://www.who.int/ith/diseases/malaria/en/ (Accessed on July 31, 2022).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Malaria: Disease. http://www.cdc.gov/malaria/about/disease.html (Accessed on July 31, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mühlberger N, Jelinek T, Gascon J, et al. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J 2004; 3:5.
          </a>
         </li>
         <li class="breakAll">
          Ashley EA, White NJ. Harrison’s Principles of Internal Medicine, 20th ed, Jameson JL, Fauci AS, Kasper DL et al (Eds), McGraw Hill, New York 2018.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durante Mangoni E, Severini C, Menegon M, et al. Case report: An unusual late relapse of Plasmodium vivax malaria. Am J Trop Med Hyg 2003; 68:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grigg MJ, Snounou G. Plasmodium simium: a Brazilian focus of anthropozoonotic vivax malaria? Lancet Glob Health 2017; 5:e961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hogan B, Eibach D, Krumkamp R, et al. Malaria Coinfections in Febrile Pediatric Inpatients: A Hospital-Based Study From Ghana. Clin Infect Dis 2018; 66:1838.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendriksen IC, White LJ, Veenemans J, et al. Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration. J Infect Dis 2013; 207:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brooker S, Akhwale W, Pullan R, et al. Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg 2007; 77:88.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. Guidelines for malaria, 25 November 2022. https://www.who.int/publications/i/item/guidelines-for-malaria (Accessed on November 30, 2022).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Treatment Guidelines: Treatment of Malaria (Guidelines for Clinicians), 2013. http://www.cdc.gov/malaria/resources/pdf/clinicalguidance.pdf (Accessed on May 11, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Severe malaria. Trop Med Int Health 2014; 19 Suppl 1:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White NJ. The treatment of malaria. N Engl J Med 1996; 335:800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devarbhavi H, Alvares JF, Kumar KS. Severe falciparum malaria simulating fulminant hepatic failure. Mayo Clin Proc 2005; 80:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Field JW. Blood examination and prognosis in acute falciparum malaria. Trans R Soc Trop Med Hyg 1949; 43:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lampah DA, Yeo TW, Malloy M, et al. Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia. J Infect Dis 2015; 211:623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bejon P, Warimwe G, Mackintosh CL, et al. Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun 2009; 77:1917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phillips A, Bassett P, Zeki S, et al. Risk factors for severe disease in adults with falciparum malaria. Clin Infect Dis 2009; 48:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGready R, Wongsaen K, Chu CS, et al. Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome. Malar J 2014; 13:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001; 64:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94 Suppl 1:S1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanley J. Malaria. Emerg Med Clin North Am 1997; 15:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reyburn H, Mbatia R, Drakeley C, et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA 2005; 293:1461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ranque S, Safeukui I, Poudiougou B, et al. Familial aggregation of cerebral malaria and severe malarial anemia. J Infect Dis 2005; 191:799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Idro R, Ndiritu M, Ogutu B, et al. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA 2007; 297:2232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hochman SE, Madaline TF, Wassmer SC, et al. Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection. MBio 2015; 6:e01390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newton CR, Kirkham FJ, Winstanley PA, et al. Intracranial pressure in African children with cerebral malaria. Lancet 1991; 337:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waller D, Crawley J, Nosten F, et al. Intracranial pressure in childhood cerebral malaria. Trans R Soc Trop Med Hyg 1991; 85:362.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jakka SR, Veena S, Atmakuri RM, Eisenhut M. Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis. Cerebrospinal Fluid Res 2006; 3:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewallen S, Bronzan RN, Beare NA, et al. Using malarial retinopathy to improve the classification of children with cerebral malaria. Trans R Soc Trop Med Hyg 2008; 102:1089.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beare NA, Taylor TE, Harding SP, et al. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg 2006; 75:790.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seydel KB, Kampondeni SD, Valim C, et al. Brain swelling and death in children with cerebral malaria. N Engl J Med 2015; 372:1126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langfitt JT, McDermott MP, Brim R, et al. Neurodevelopmental Impairments 1 Year After Cerebral Malaria. Pediatrics 2019; 143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mung'Ala-Odera V, Snow RW, Newton CR. The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa. Am J Trop Med Hyg 2004; 71:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christensen SS, Eslick GD. Cerebral malaria as a risk factor for the development of epilepsy and other long-term neurological conditions: a meta-analysis. Trans R Soc Trop Med Hyg 2015; 109:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sahuguet J, Poulet A, Bou Ali H, et al. Postmalaria Neurologic Syndrome-Autoimmune Encephalitis With Anti-Voltage-Gated Potassium-Channel Antibodies. Ann Intern Med 2017; 167:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batte A, Starr MC, Schwaderer AL, et al. Methods to estimate baseline creatinine and define acute kidney injury in lean Ugandan children with severe malaria: a prospective cohort study. BMC Nephrol 2020; 21:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conroy AL, Hawkes M, Elphinstone RE, et al. Acute Kidney Injury Is Common in Pediatric Severe Malaria and Is Associated With Increased Mortality. Open Forum Infect Dis 2016; 3:ofw046.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Namazzi R, Batte A, Opoka RO, et al. Acute kidney injury, persistent kidney disease, and post-discharge morbidity and mortality in severe malaria in children: A prospective cohort study. EClinicalMedicine 2022; 44:101292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conroy AL, Opoka RO, Bangirana P, et al. Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria. BMC Med 2019; 17:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hickson MR, Conroy AL, Bangirana P, et al. Acute kidney injury in Ugandan children with severe malaria is associated with long-term behavioral problems. PLoS One 2019; 14:e0226405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barsoum RS. Malarial acute renal failure. J Am Soc Nephrol 2000; 11:2147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor WR, Hanson J, Turner GD, et al. Respiratory manifestations of malaria. Chest 2012; 142:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 1998; 27:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berkley JA, Bejon P, Mwangi T, et al. HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis 2009; 49:336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morpeth SC, Ramadhani HO, Crump JA. Invasive non-Typhi Salmonella disease in Africa. Clin Infect Dis 2009; 49:606.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendriksen IC, Ferro J, Montoya P, et al. Diagnosis, clinical presentation, and in-hospital mortality of severe malaria in HIV-coinfected children and adults in Mozambique. Clin Infect Dis 2012; 55:1144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Otieno RO, Ouma C, Ong'echa JM, et al. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 2006; 20:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mermin J, Lule JR, Ekwaru JP. Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 2006; 41:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alemu A, Shiferaw Y, Addis Z, et al. Effect of malaria on HIV/AIDS transmission and progression. Parasit Vectors 2013; 6:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franke MF, Spiegelman D, Ezeamama A, et al. Malaria parasitemia and CD4 T cell count, viral load, and adverse HIV outcomes among HIV-infected pregnant women in Tanzania. Am J Trop Med Hyg 2010; 82:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kublin JG, Patnaik P, Jere CS, et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005; 365:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffman IF, Jere CS, Taylor TE, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999; 13:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subramaniam K, Plank RM, Lin N, et al. Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults. Open Forum Infect Dis 2014; 1:ofu066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dondorp AM, Lee SJ, Faiz MA, et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis 2008; 47:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hulbert TV. Congenital malaria in the United States: report of a case and review. Clin Infect Dis 1992; 14:922.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vinetz JM, Li J, McCutchan TF, Kaslow DC. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med 1998; 338:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA 2007; 297:2264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ndyomugyenyi R, Magnussen P, Clarke S. Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda. Malar J 2007; 6:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ndyomugyenyi R, Magnussen P, Clarke S. Malaria treatment-seeking behaviour and drug prescription practices in an area of low transmission in Uganda: implications for prevention and control. Trans R Soc Trop Med Hyg 2007; 101:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luxemburger C, Nosten F, Kyle DE, et al. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. Trans R Soc Trop Med Hyg 1998; 92:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chandramohan D, Carneiro I, Kavishwar A, et al. A clinical algorithm for the diagnosis of malaria: results of an evaluation in an area of low endemicity. Trop Med Int Health 2001; 6:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mwangi TW, Mohammed M, Dayo H, et al. Clinical algorithms for malaria diagnosis lack utility among people of different age groups. Trop Med Int Health 2005; 10:530.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vinnemeier CD, Schwarz NG, Sarpong N, et al. Predictive value of fever and palmar pallor for P. falciparum parasitaemia in children from an endemic area. PLoS One 2012; 7:e36678.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patrick Kachur S, Schulden J, Goodman CA, et al. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Trop Med Int Health 2006; 11:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkins H, Bebell L, Kambale W, et al. Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis 2008; 197:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olivar M, Develoux M, Chegou Abari A, Loutan L. Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel. Trans R Soc Trop Med Hyg 1991; 85:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor SM, Molyneux ME, Simel DL, et al. Does this patient have malaria? JAMA 2010; 304:2048.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5709 Version 41.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17516399" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Fever in returned travelers: results from the GeoSentinel Surveillance Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7717795" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Imported malaria. Clinical presentation and examination of symptomatic travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14561793" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Delayed onset of malaria--implications for chemoprophylaxis in travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14561793" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Delayed onset of malaria--implications for chemoprophylaxis in travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14561793" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Delayed onset of malaria--implications for chemoprophylaxis in travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15003128" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15003128" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12641405" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Case report: An unusual late relapse of Plasmodium vivax malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28867402" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Plasmodium simium: a Brazilian focus of anthropozoonotic vivax malaria?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29408951" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Malaria Coinfections in Febrile Pediatric Inpatients: A Hospital-Based Study From Ghana.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23136222" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18165479" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18165479" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18165479" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25214480" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Severe malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8703186" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The treatment of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15757017" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Severe falciparum malaria simulating fulminant hepatic failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18139104" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Blood examination and prognosis in acute falciparum malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25170106" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19223480" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19243243" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Risk factors for severe disease in adults with falciparum malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24886559" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11425175" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The burden of malaria in pregnancy in malaria-endemic areas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11103309" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9056573" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15784869" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15688298" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Familial aggregation of cerebral malaria and severe malarial anemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17519413" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26396242" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1671941" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Intracranial pressure in African children with cerebral malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1949139" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Intracranial pressure in childhood cerebral malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16764711" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18760435" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Using malarial retinopathy to improve the classification of children with cerebral malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17123967" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Malarial retinopathy: a newly established diagnostic sign in severe malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25785970" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Brain swelling and death in children with cerebral malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30696757" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Neurodevelopmental Impairments 1 Year After Cerebral Malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15331820" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25631856" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Cerebral malaria as a risk factor for the development of epilepsy and other long-term neurological conditions: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28505668" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Postmalaria Neurologic Syndrome-Autoimmune Encephalitis With Anti-Voltage-Gated Potassium-Channel Antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32993548" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Methods to estimate baseline creatinine and define acute kidney injury in lean Ugandan children with severe malaria: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27186577" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Acute Kidney Injury Is Common in Pediatric Severe Malaria and Is Associated With Increased Mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35198918" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Acute kidney injury, persistent kidney disease, and post-discharge morbidity and mortality in severe malaria in children: A prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31109328" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31846479" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Acute kidney injury in Ugandan children with severe malaria is associated with long-term behavioral problems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11053494" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Malarial acute renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22871759" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Respiratory manifestations of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9675468" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Imported malaria: prospective analysis of problems in diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19548833" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19591599" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Invasive non-Typhi Salmonella disease in Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22752514" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Diagnosis, clinical presentation, and in-hospital mortality of severe malaria in HIV-coinfected children and adults in Mozambique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16511422" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16340488" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Association between malaria and CD4 cell count decline among persons with HIV.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23327493" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Effect of malaria on HIV/AIDS transmission and progression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20348498" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Malaria parasitemia and CD4 T cell count, viral load, and adverse HIV outcomes among HIV-infected pregnant women in Tanzania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15652606" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10197377" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25734136" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18533842" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : The relationship between age and the manifestations of and mortality associated with severe malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1576289" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Congenital malaria in the United States: report of a case and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9449730" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17519416" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Treatment of malaria in the United States: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17407555" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16950487" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Malaria treatment-seeking behaviour and drug prescription practices in an area of low transmission in Uganda: implications for prevention and control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9692150" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11469942" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : A clinical algorithm for the diagnosis of malaria: results of an evaluation in an area of low endemicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15941415" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Clinical algorithms for malaria diagnosis lack utility among people of different age groups.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22574213" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Predictive value of fever and palmar pallor for P. falciparum parasitaemia in children from an endemic area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16553927" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18240951" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1801337" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21057136" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Does this patient have malaria?
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
